ARCHIVES

NCI Awards $59M Contract For Key Project To consolidate Phase III Trial Administration

This article is from The Cancer Letter archive.

Vol. 25 No. 41 | October 29, 1999

Download PDF Visit The Full Archive

Related Articles

Device Shortens Time To Make T Cells For Immunotherapy

March 27, 2009

HCFA Sees Applications For DRGs And Research

September 27, 1985

New ACS Grants to Fund ‘Critical, Urgent’ Research

April 15, 1977

Lung Screening Study Ties Up Advisors, Board Sends It Back To NCI For Revision.

June 29, 2001

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

April 29, 1988

Crout Resigns As Director Of FDA Drugs Bureau

July 11, 1980